Fispghan

Fispghan Federation of the International Societies for Pediatric Gastroenterology, Hepatology and Nutrition (FISPGHAN)

10/26/2025

Prof Iva Hojsak at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

10/25/2025

Dr Luciana Silva from Brazil at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

10/25/2025

Prof Lizzy de Ridder at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

10/24/2025

Dr Dan Turner from Israel at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

10/24/2025

Dr Jorge Amil from Portugal at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

Our past-president, Dr. Marina Orsi, presenting her scientific work at the 7th International Symposium on Pediatric Infl...
10/23/2025

Our past-president, Dr. Marina Orsi, presenting her scientific work at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

10/23/2025

Dr Javier Martín de Carpi from Spain at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

This month in JPGN Reports: Isolated gastrointestinal Langerhans cell histiocytosis in a 16-month-old child: A case repo...
10/23/2025

This month in JPGN Reports: Isolated gastrointestinal Langerhans cell histiocytosis in a 16-month-old child: A case report.
Al-Qasim AL-Bahlani, Laraib Touseeq, Mohammed Al-Masqari, Emad Saad
https://doi.org/10.1002/jpr3.70096

Langerhans cell histiocytosis (LCH) is a rare disorder characterized by clonal proliferation of Langerhans cells, most often involving the skin or bone. Isolated gastrointestinal (GI) involvement is extremely uncommon in young children. We report a 16-month-old girl with a 1-month history of chronic vomiting, bloody diarrhea, and failure to thrive who was found to have GI-LCH without systemic involvement. She was started on standard LCH chemotherapy with a favorable clinical response. This case highlights the importance of considering LCH in infants/toddlers with unexplained GI symptoms and the utility of targeted molecular testing (e.g., BRAF mutation analysis) in guiding therapy.

10/23/2025

Our past president Dr Marina Orsi at the 7th International Symposium on Pediatric Inflammatory Bowel Disease

10/22/2025

PIBD 2025 SORRENTO
7th International Symposium on Pediatric Inflammatory Bowel Disease
For FISPGHAN Publicity Group, Dr Natascha Sandy from Brazil

This month in JPGN Reports: Expect the unexpected: A case of penetrating Crohn's disease complicated by foreign body in...
10/22/2025

This month in JPGN Reports: Expect the unexpected: A case of penetrating Crohn's disease complicated by foreign body ingestion
Meredith R. Kline, Baddr A. Shakhsheer, Amelia Kellar
https://doi.org/10.1002/jpr3.70095

A 17-year-old nonverbal male with autism spectrum disorder (ASD) presented with abdominal pain, diarrhea, and weight loss. Initial workup revealed penetrating Crohn's disease (CD) with an ileosigmoid fistula and abscess. After initial improvement with antibiotics, enteral nutrition (EN), and infliximab (IFX), he developed recurrent abdominal pain and elevation of inflammatory markers. Repeat imaging suggested disease progression, prompting surgical intervention. During ileocecal resection and fistula takedown, a foreign body (the hand of an action figurine) was discovered, likely contributing to bowel obstruction and abscess recurrence. This case highlights the importance of medical and surgical comanagement of penetrating CD, as well as the need to maintain a broad differential diagnosis when new or worsening symptoms arise.

This month in JPGN Reports: Youngest known case of a pancreatic perivascular epithelioid cell tumorLaura Gilligan, Wesle...
10/21/2025

This month in JPGN Reports: Youngest known case of a pancreatic perivascular epithelioid cell tumor
Laura Gilligan, Wesley C. Judy, Bryan Clary, Timothy Fairbanks, Denise Malicki, Tom K. Lin
https://doi.org/10.1002/jpr3.70094

Perivascular epithelioid cell tumors (PEComas) are a rare type of mesenchymal tumor that can arise in any part of the body. As of 2024, 37 cases of pancreatic PEComas had been reported in the literature with patients ranging in age from 17 to 74 years old. This is the youngest reported case of a pancreatic PEComa in an 8-year-old female presenting with abdominal pain and test findings of biliary obstruction. Magnetic resonance cholangiopancreatography identified the location, size, and obstructive effects of the mass. These findings prompted the performance of an endoscopic retrograde cholangiopancreatography and endoscopic ultrasound with fine-needle aspiration to obtain a tissue sample that revealed the diagnosis of PEComa based on the morphological features and immunohistochemistry. Our patient's tumor was benign, successfully resected, and to date, the child has not had tumor recurrence based upon postsurgical serial imaging, which is consistent with most cases of pancreatic PEComas.

Address

Spring House, PA
19002

Website

Alerts

Be the first to know and let us send you an email when Fispghan posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category